Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Active Adults, 18 to 35 Years Old, With Major Depressive Disorder Who Are in a School or Work Environment

ClinicalTrials.gov ID: NCT02013609

Public ClinicalTrials.gov record NCT02013609. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Sep 2, 2026, 1:06 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Protocol 331-13-003: An Exploratory, Multicenter, Open-label, Flexible-dose Trial of Brexpiprazole (OPC 34712) as an Adjunctive Treatment in Active Adults, 18 to 35 Years Old, With Major Depressive Disorder Who Are in a School or Work Environment.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To investigate the efficacy and safety of flexibly dosed adjunctive brexpiprazole treatment in active adults with MDD, 18 to 35 years old, who are experiencing an inadequate selective serotonin reuptake inhibitor (SSRI)/serotonin norepinephrine reuptake inhibitor (SNRI) response in a school or work environment.

Study identification

NCT ID: NCT02013609
Recruitment status: Completed
Study type: Interventional
Phase: Phase 3
Lead sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.; Industry
Enrollment: 48 participants

Conditions and interventions

Conditions

Interventions

Brexpiprazole Drug

Drug

Eligibility (public fields only)

Age range: 18 Years to 35 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Oct 31, 2013
Primary completion: Aug 31, 2014
Completion: Sep 30, 2014
Last update posted: Mar 28, 2016

2013 – 2014

United States locations

U.S. sites: 24
U.S. states: 11
U.S. cities: 24

Facility	City	State	ZIP	Site status
Not listed	Cerritos	California	90703	—
Not listed	Costa Mesa	California	92626	—
Not listed	Garden Grove	California	92845	—
Not listed	Glendale	California	91206	—
Not listed	Orange	California	92868	—
Not listed	Riverside	California	92506	—
Not listed	San Diego	California	92121	—
Not listed	Norwich	Connecticut	06360	—
Not listed	Fort Myers	Florida	33912	—
Not listed	Hialeah	Florida	33016	—
Not listed	Melbourne	Florida	32901	—
Not listed	Orlando	Florida	32806	—
Not listed	Atlanta	Georgia	30328	—
Not listed	Prairie Village	Kansas	66206	—
Not listed	Weymouth	Massachusetts	02190	—
Not listed	Las Vegas	Nevada	89102	—
Not listed	Brooklyn	New York	11235	—
Not listed	Jamaica	New York	11235	—
Not listed	Staten Island	New York	10312	—
Not listed	Portland	Oregon	97210	—
Not listed	Austin	Texas	78731	—
Not listed	Houston	Texas	77007	—
Not listed	San Antonio	Texas	78229	—
Not listed	Seattle	Washington	98104	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT02013609, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Mar 28, 2016 · Synced Sep 2, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02013609 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →